Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-11

Clinical Trial Update: Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Massachusetts General Hospital evaluating stress reduction techniques on anxiety and related neuroendocrine changes in Genera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-06-11